
Methyl all-cis-5,8,11,14-eicosatetraenoate | CAS:2566-89-4
Methyl all-cis-5,8,11,14-eicosatetraenoate
- 名称:全顺式-5,8,11,14-二十碳四烯酸甲酯 | Methyl all-cis-5,8,11,14-eicosatetraenoate
- CAS号:2566-89-4
- 别名:(5Z,8Z,11Z,14Z)-5,8,11,14-Eicosatetraenoic acid methyl ester
- 分子式:C21H34O2
- 分子量:318.49
- EINESC号:219-900-1
产品描述
物理化学性质
沸点 | 200-205 ºC (1-2 Torr)** |
---|---|
闪点 | 102.0±24.0 ºC, 计算值* |
密度 | 0.901±0.06 g/cm3 (20 º |
折射率 | 1.4875 (589.3 nm 20 ºC)*** |
安全数据
没有数据 | 没有数据 |
---|
SDS
来源 | SDS样本 |
---|---|
没有数据 | 没有数据 |
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.Keita Sugiura et al.Antimicrobial agents and chemotherapy, 58(7), 3837-3842 (2014-04-23)
Ciclopirox olamine: a hydroxypyridone antifungal agent.B B Abrams et al.Clinics in dermatology, 9(4), 471-477 (1991-10-01)
Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.Luis Nogueiras-Nieto et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(3), 370-377 (2012-12-04)
Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.Anja Täuber et al.Molecular pharmaceutics, 11(7), 1991-1996 (2014-02-05)
Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.Young Kim et al.In vivo (Athens, Greece), 25(6), 887-893 (2011-10-25)
Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.Shaikh Karimunnisa et al.Drug development and industrial pharmacy, 39(9), 1328-1337 (2012-08-08)
Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.Sae Hee Ko et al.PloS one, 6(11), e27844-e27844 (2011-11-30)
Hypoxic ventilatory response in limited iron in the rat.M Pokorski et al.Journal of biological regulators and homeostatic agents, 26(4), 653-661 (2012-12-18)
Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.P Chouhan et al.International journal of pharmaceutics, 436(1-2), 179-182 (2012-06-19)
Interaction between ciclopirox and acenocoumarol.José A Morales-Molina et al.European journal of clinical pharmacology, 69(3), 727-728 (2012-07-14)
Determination of ciclopirox olamine in pharmaceutical products by capillary electrophoresis with capacitively coupled contactless conductivity detection.Fabiana Silva Felix et al.Electrophoresis, 32(8), 900-905 (2011-03-12)
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.Mark D Minden et al.American journal of hematology, 89(4), 363-368 (2013-11-26)
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.Siyuan Song et al.Cancer research, 71(24), 7628-7639 (2011-10-20)
Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death.Ludmila de Matos Baltazar et al.The Journal of antimicrobial chemotherapy, 68(2), 354-361 (2012-11-09)
Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.Vanessa Alves Pinheiro et al.Pharmaceutical development and technology, 20(2), 197-203 (2013-11-30)
Ciclopirox olamine: head to foot.F Emily Bell et al.Journal of drugs in dermatology : JDD, 2(1), 50-51 (2003-07-11)
Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.Luis Nogueiras-Nieto et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 80(3), 585-595 (2011-12-21)
Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.Christiane M Koller et al.Anticancer research, 33(6), 2435-2440 (2013-06-12)
Case report: onychomycosis due to Trichophyton schoenleinii.Anna B Macura et al.Mycoses, 55(2), e18-e19 (2011-07-21)
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.Tsuyoshi Shimamura et al.Antimicrobial agents and chemotherapy, 55(7), 3150-3155 (2011-05-11)
[Candida glabrata : pathogenicity and therapy update].H-J Tietz Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 63(11), 868-871 (2012-08-29)
Ciclopirox olamine 1% cream. A preliminary review of its antimicrobial activity and therapeutic use.S G Jue et al.Drugs, 29(4), 330-341 (1985-04-01)
Targeting the Wnt/beta-catenin pathway in multiple myeloma.Leonard Christopher Schmeel et al.Anticancer research, 33(11), 4719-4726 (2013-11-14)
A hypusine-eIF5A-PEAK1 switch regulates the pathogenesis of pancreatic cancer.Ken Fujimura et al.Cancer research, 74(22), 6671-6681 (2014-09-28)
Validation of bovine hoof slices as a model for infected human toenails: in vitro ciclopirox transungual permeation.D Monti et al.The British journal of dermatology, 165(1), 99-105 (2011-03-18)
Oligodendrocytes Provide Antioxidant Defense Function for Neurons by Secreting Ferritin Heavy Chain.Chaitali Mukherjee et al.Cell metabolism, 32(2), 259-272 (2020-06-13)
[When the nail is the polished one]. MMW Fortschritte der Medizin, 154(10), 24-24 (2012-07-19)
Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.Ígor B Cursi et al.Mycopathologia, 175(1-2), 75-82 (2012-09-15)
Nail penetration and predicted mycological efficacy of an innovative hydrosoluble ciclopirox nail lacquer vs. a standard amorolfine lacquer in healthy subjects.D Monti et al.Journal of the European Academy of Dermatology and Venereology : JEADV, 27(2), e153-e158 (2012-03-28)
Recurrent vulvovaginal candidosis: focus on the vulva.Florian C Beikert et al.Mycoses, 54(6), e807-e810 (2011-05-28)
The repositioning of the anti-fungal agent ciclopirox olamine as a novel therapeutic agent for the treatment of haematologic malignancy.S J Weir et al.Journal of clinical pharmacy and therapeutics, 36(2), 128-134 (2011-03-04)
Novel mTOR inhibitory activity of ciclopirox enhances parthenolide antileukemia activity.Siddhartha Sen et al.Experimental hematology, 41(9), 799-807 (2013-05-11)
Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.Fernanda Simas Corrêa Biancalana et al.Mycopathologia, 172(4), 279-285 (2011-05-26)
Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.Sergio Schalka et al.Anais brasileiros de dermatologia, 87(1), 19-25 (2012-04-07)
Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.Christian Diehl et al.Journal of drugs in dermatology : JDD, 12(3), 312-315 (2013-04-03)
Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies.Mark D Minden et al.American journal of hematology, 89(4), 363-368 (2013-11-26)
Photodynamic inhibition of Trichophyton rubrum: in vitro activity and the role of oxidative and nitrosative bursts in fungal death.Ludmila de Matos Baltazar et al.The Journal of antimicrobial chemotherapy, 68(2), 354-361 (2012-11-09)
Development of ciclopirox olamine topical formulations: evaluation of drug release, penetration and cutaneous retention.Vanessa Alves Pinheiro et al.Pharmaceutical development and technology, 20(2), 197-203 (2013-11-30)
Ciclopirox olamine: head to foot.F Emily Bell et al.Journal of drugs in dermatology : JDD, 2(1), 50-51 (2003-07-11)
Competitive displacement of drugs from cyclodextrin inclusion complex by polypseudorotaxane formation with poloxamer: implications in drug solubilization and delivery.Luis Nogueiras-Nieto et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 80(3), 585-595 (2011-12-21)
Targeting renal cancer with a combination of WNT inhibitors and a bi-functional peptide.Christiane M Koller et al.Anticancer research, 33(6), 2435-2440 (2013-06-12)
Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients.Ígor B Cursi et al.Mycopathologia, 175(1-2), 75-82 (2012-09-15)
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling.Elvira Sondo et al.American journal of physiology. Cell physiology, 301(4), C872-C885 (2011-07-15)
Determination of ciclopirox olamine in pharmaceutical products by capillary electrophoresis with capacitively coupled contactless conductivity detection.Fabiana Silva Felix et al.Electrophoresis, 32(8), 900-905 (2011-03-12)
Establishment of a novel model of onychomycosis in rabbits for evaluation of antifungal agents.Tsuyoshi Shimamura et al.Antimicrobial agents and chemotherapy, 55(7), 3150-3155 (2011-05-11)
Wnt inhibitor screen reveals iron dependence of β-catenin signaling in cancers.Siyuan Song et al.Cancer research, 71(24), 7628-7639 (2011-10-20)
The low keratin affinity of efinaconazole contributes to its nail penetration and fungicidal activity in topical onychomycosis treatment.Keita Sugiura et al.Antimicrobial agents and chemotherapy, 58(7), 3837-3842 (2014-04-23)
Comparison of visual assessments versus planimetry assessments in a large-scale clinical trial of onychomycosis.Aditya K Gupta et al.The Journal of dermatological treatment, 25(3), 256-259 (2012-05-30)
The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.Agron Starova et al.Expert opinion on drug safety, 4(2), 235-239 (2005-03-30)
Antimycotic ciclopirox olamine in the diabetic environment promotes angiogenesis and enhances wound healing.Sae Hee Ko et al.PloS one, 6(11), e27844-e27844 (2011-11-30)
Fungicidal drugs induce a common oxidative-damage cellular death pathway.Peter Belenky et al.Cell reports, 3(2), 350-358 (2013-02-19)
Tinea corporis bullosa due to Trichophyton schoenleinii: case report.Mihai Mareş et al.Mycopathologia, 174(4), 319-322 (2012-05-12)
Hydration of nail plate: a novel screening model for transungual drug permeation enhancers.P Chouhan et al.International journal of pharmaceutics, 436(1-2), 179-182 (2012-06-19)
Interaction between ciclopirox and acenocoumarol.José A Morales-Molina et al.European journal of clinical pharmacology, 69(3), 727-728 (2012-07-14)
Rescue of the mutant CFTR chloride channel by pharmacological correctors and low temperature analyzed by gene expression profiling.Elvira Sondo et al.American journal of physiology. Cell physiology, 301(4), C872-C885 (2011-07-15)
Comparison of visual assessments versus planimetry assessments in a large-scale clinical trial of onychomycosis.Aditya K Gupta et al.The Journal of dermatological treatment, 25(3), 256-259 (2012-05-30)
The safety and efficacy of ciclopirox olamine for the treatment of seborrheic dermatitis.Agron Starova et al.Expert opinion on drug safety, 4(2), 235-239 (2005-03-30)
Fungicidal drugs induce a common oxidative-damage cellular death pathway.Peter Belenky et al.Cell reports, 3(2), 350-358 (2013-02-19)
Tinea corporis bullosa due to Trichophyton schoenleinii: case report.Mihai Mareş et al.Mycopathologia, 174(4), 319-322 (2012-05-12)
Standardization of hyphal growth inhibition rate as a means of evaluating Microsporum spp. in vitro susceptibility to terbinafine, griseofulvin, and ciclopiroxolamine.Fernanda Simas Corrêa Biancalana et al.Mycopathologia, 172(4), 279-285 (2011-05-26)
Comparative clinical evaluation of efficacy and safety of a formulation containing ciclopirox 8% in the form of a therapeutic nail lacquer in two different posologies for the treatment of onychomycosis of the toes.Sergio Schalka et al.Anais brasileiros de dermatologia, 87(1), 19-25 (2012-04-07)
Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study.Christian Diehl et al.Journal of drugs in dermatology : JDD, 12(3), 312-315 (2013-04-03)
Hypoxic ventilatory response in limited iron in the rat.M Pokorski et al.Journal of biological regulators and homeostatic agents, 26(4), 653-661 (2012-12-18)
Ciclopirox olamine: a hydroxypyridone antifungal agent.B B Abrams et al.Clinics in dermatology, 9(4), 471-477 (1991-10-01)
Thermogelling hydrogels of cyclodextrin/poloxamer polypseudorotaxanes as aqueous-based nail lacquers: application to the delivery of triamcinolone acetonide and ciclopirox olamine.Luis Nogueiras-Nieto et al.European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V, 83(3), 370-377 (2012-12-04)
Comparison of the antifungal efficacy of terbinafine hydrochloride and ciclopirox olamine containing formulations against the dermatophyte Trichophyton rubrum in an infected nail plate model.Anja Täuber et al.Molecular pharmaceutics, 11(7), 1991-1996 (2014-02-05)
Targeting the Wnt/beta-catenin pathway with the antifungal agent ciclopirox olamine in a murine myeloma model.Young Kim et al.In vivo (Athens, Greece), 25(6), 887-893 (2011-10-25)
[When the nail is the polished one]. MMW Fortschritte der Medizin, 154(10), 24-24 (2012-07-19)
[Candida glabrata : pathogenicity and therapy update].H-J Tietz Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 63(11), 868-871 (2012-08-29)
Mucoadhesive nanoliposomal formulation for vaginal delivery of an antifungal.Shaikh Karimunnisa et al.Drug development and industrial pharmacy, 39(9), 1328-1337 (2012-08-08)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!